30+ years of pharmaceutical leadership. Former VP at Takeda Pharmaceutical. Holds PhD in Organic Chemistry from University of Tokyo.
Former Finance Director at GlaxoSmithKline. Chartered Accountant with expertise in global M&A and capital markets.
25 years in pharmaceutical manufacturing. Led operations at Pfizer and Merck. Expert in GMP compliance and supply chain.
PhD in Pharmaceutical Sciences from MIT. 20+ patents in drug delivery systems. Former head of R&D at Novartis Japan.
Board-certified physician with MBA from INSEAD. Former Global Medical Director at AstraZeneca. Expert in clinical trials.
Former Partner at McKinsey Healthcare. MBA from Harvard Business School. Specializes in emerging market expansion.
Takeshi Yamamoto brings over three decades of experience in the global pharmaceutical industry to SNF Agrochemicals Limited. As CEO, he oversees the company's strategic direction, international expansion, and commitment to innovation in healthcare and agriculture.
Before joining SNF, Takeshi served as Vice President of Global Operations at Takeda Pharmaceutical Company, where he led manufacturing operations across 15 countries and managed a portfolio exceeding $5 billion in annual revenue.
Takeshi serves on the board of the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) and is a frequent speaker at the World Economic Forum on healthcare access and innovation. He is also an advisor to the Japanese Ministry of Health on pharmaceutical policy reform.
Sarah Mitchell is a seasoned financial executive with extensive experience in the pharmaceutical and healthcare sectors. As CFO of SNF Agrochemicals Limited, she manages the company's financial strategy, investor relations, and global treasury operations across Japan, the UK, and the USA.
Prior to SNF, Sarah spent 18 years at GlaxoSmithKline, where she held progressively senior roles including Finance Director for the European Operations and VP of Corporate Development, overseeing mergers and acquisitions valued at over $3 billion.
Sarah is a member of the CFO Leadership Network and serves as treasurer for the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation. She is also a mentor for Women in Pharma Finance, promoting gender diversity in financial leadership roles.
James Richardson is an operations excellence leader with 25 years of experience in pharmaceutical manufacturing and supply chain management. As COO, he ensures SNF's global production facilities meet the highest standards of quality, efficiency, and regulatory compliance.
James previously held senior operations roles at Pfizer and Merck, where he managed manufacturing plants in the USA, Ireland, and Singapore. He is recognized for his expertise in Lean Six Sigma, GMP compliance, and digital transformation of manufacturing processes.
James serves on the board of the International Society for Pharmaceutical Engineering (ISPE) and chairs the Global Manufacturing Excellence Committee. He is a frequent contributor to industry journals on topics of operational excellence and sustainable manufacturing.
Dr. Wei Chen is a renowned pharmaceutical scientist and technology innovator. As CTO, he leads SNF's global research and development efforts, driving breakthrough innovations in drug delivery, formulation science, and green chemistry.
Before joining SNF, Dr. Chen was Head of R&D at Novartis Japan, where he led a team of 300 scientists and managed a pipeline of 45 active development programs. He holds over 20 patents in advanced drug delivery systems and nanotechnology.
Dr. Chen is a member of the American Association of Pharmaceutical Scientists (AAPS) and serves on the editorial board of the Journal of Controlled Release. He is also a visiting professor at the University of Tokyo's Graduate School of Pharmaceutical Sciences.
Dr. Elena Vasquez is a board-certified physician and healthcare executive who brings deep clinical expertise and strategic vision to SNF's medical and regulatory affairs. As CMO, she ensures all products meet the highest standards of safety, efficacy, and regulatory compliance.
Prior to SNF, Dr. Vasquez served as Global Medical Director at AstraZeneca, where she oversaw clinical development programs for cardiovascular and metabolic diseases. She has led over 50 clinical trials across four continents.
Dr. Vasquez is a member of the European Medicines Agency's Scientific Advice Working Party and serves on the board of the Clinical Trials Transformation Initiative (CTTI). She is a passionate advocate for diversity in clinical research.
Robert Kim is a strategic leader with deep expertise in healthcare market expansion, M&A, and corporate development. As CSO, he shapes SNF's long-term growth strategy, identifying new market opportunities and guiding strategic partnerships.
Before SNF, Robert was a Partner at McKinsey & Company's Healthcare Practice, where he advised Fortune 500 pharmaceutical companies on growth strategy, market entry, and portfolio optimization across Asia, Europe, and the Americas.
Robert is a member of the Asia-Pacific Healthcare CEO Council and serves as an advisor to several healthcare venture capital funds. He is a regular speaker at the JP Morgan Healthcare Conference and the BIO International Convention.
Select your preferred language to translate this website.
Insert Translator Plugin Here